These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739 [TBL] [Abstract][Full Text] [Related]
4. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy. Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654 [TBL] [Abstract][Full Text] [Related]
6. Factors associated with overall survival in 1706 patients with nasopharyngeal carcinoma: significance of intensive neoadjuvant chemotherapy and radiation break. Xu L; Pan J; Wu J; Pan C; Zhang Y; Lin S; Yang L; Chen C; Zhang C; Zheng W; Lin S; Ni X; Kong FM Radiother Oncol; 2010 Jul; 96(1):94-9. PubMed ID: 20435361 [TBL] [Abstract][Full Text] [Related]
7. Early stage nasopharyngeal carcinoma: radiotherapy dose and time factors in tumor control. Chang JT; See LC; Liao CT; Chen LH; Leung WM; Chen SW; Chen WC Jpn J Clin Oncol; 1998 Mar; 28(3):207-13. PubMed ID: 9614445 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma. Yau TK; Sze WM; Lee WM; Yeung MW; Leung KC; Hung WM; Chan WI Head Neck; 2004 Dec; 26(12):1024-30. PubMed ID: 15390194 [TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and outcome for nasopharyngeal carcinoma. Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084 [TBL] [Abstract][Full Text] [Related]
10. Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data, intelligence platform-based analysis. Huang XD; Zhou GQ; Lv JW; Zhou HQ; Zhong CW; Wu CF; Zheng ZQ; He XJ; Peng L; Ma J; Sun Y Radiother Oncol; 2018 Nov; 129(2):389-395. PubMed ID: 30270098 [TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal carcinoma in children and adolescents in an endemic area: a report of 185 cases. Yan Z; Xia L; Huang Y; Chen P; Jiang L; Zhang B Int J Pediatr Otorhinolaryngol; 2013 Sep; 77(9):1454-60. PubMed ID: 23830224 [TBL] [Abstract][Full Text] [Related]
13. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175 [TBL] [Abstract][Full Text] [Related]
14. The role of brachytherapy in early-stage nasopharyngeal carcinoma. Chang JT; See LC; Tang SG; Lee SP; Wang CC; Hong JH Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1019-24. PubMed ID: 8985022 [TBL] [Abstract][Full Text] [Related]
15. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma. Lee CC; Chu ST; Chou P; Lee CC; Chen LF Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377 [TBL] [Abstract][Full Text] [Related]
16. Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma. Lee CC; Chu ST; Chou P Auris Nasus Larynx; 2009 Dec; 36(6):688-94. PubMed ID: 19410399 [TBL] [Abstract][Full Text] [Related]
17. High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}. Leung TW; Wong VY; Sze WK; Lui CM; Tung SY Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):361-7. PubMed ID: 17892917 [TBL] [Abstract][Full Text] [Related]
18. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG). Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829 [TBL] [Abstract][Full Text] [Related]
19. Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: Long-term outcomes of 512 patients from a single institution. Li G; Gao J; Liu ZG; Tao YL; Xu BQ; Tu ZW; Zhang XP; Zeng MS; Xia YF Head Neck; 2014 May; 36(5):660-6. PubMed ID: 23606535 [TBL] [Abstract][Full Text] [Related]
20. Improved local control for early T-stage nasopharyngeal carcinoma--a tale of two hospitals. Teo PM; Leung SF; Fowler J; Leung TW; Tung Y; O SK; Lee WY; Zee B Radiother Oncol; 2000 Nov; 57(2):155-66. PubMed ID: 11054519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]